>>It's a bit rich at present, but for the reasons you've mentioned, Stryker Corp. and Medtronic probably have a steady, long growth climb in front of them. I think medical devices may be less problematic than drugs for a while.<<
They are certainly less controversial. Here’s an oldie but goodie on the demographic tailwind in orthopedics:
Market Data 
Markets 
AI
